Cutler Group’s ResMed RMD Stock Holding History

Cutler Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$28K	Sell	2,500 -500	-17%	-$91.6K	0.01%	899
2023 Q4	$12K	Buy	+3,000	New	+$461K	﹤0.01%	2299
2021 Q3	–	Sell	-1,200	Closed	-$17K	–	6258
2021 Q2	$17K	Buy	+1,200	New	+$252K	﹤0.01%	3454
2019 Q1	–	Sell	-3,000	Closed	-$6K	–	4639
2018 Q4	$6K	Hold	3,000	–	–	﹤0.01%	2850
2018 Q3	$12K	Buy	+3,000	New	+$329K	﹤0.01%	2555
2017 Q4	–	Sell	-3,300	Closed	-$1K	–	5755
2017 Q3	$1K	Sell	3,300 -4,300	-57%	-$329K	﹤0.01%	5522
2017 Q2	$3K	Buy	+7,600	New	+$544K	﹤0.01%	5289
2017 Q1	–	Sell	-9,400	Closed	-$20K	–	7067
2016 Q4	$20K	Buy	9,400 +3,100	+49%	+$190K	﹤0.01%	3476
2016 Q3	$30K	Buy	6,300 +4,000	+174%	+$266K	﹤0.01%	3015
2016 Q2	$8K	Buy	2,300 +500	+28%	+$29.5K	﹤0.01%	4452
2016 Q1	$10K	Sell	1,800 -18,300	-91%	-$1.04M	﹤0.01%	4049
2015 Q4	$76K	Buy	+20,100	New	+$1.13M	﹤0.01%	2030

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cutler Group's RMD Position: Q3 2017 in Review

Cutler Group sold out of ResMed (RMD) in Q3 2017, closing a stake of 8,624 shares — an estimated $660K sold.

Cutler Group first reported a position in RMD in Q2 2016 and held it in 4 quarters. The position peaked at $673K in Q1 2017. 362 funds tracked by Wall St. Rank hold RMD as of Q3 2017.

Cutler Group reported no remaining ResMed position as of Q3 2017 after selling out during the quarter.
Cutler Group sold 8,624 ResMed shares in Q3 2017, an estimated $660K.
Cutler Group first reported a position in ResMed in Q2 2016 and held it in 4 quarters.
Cutler Group's ResMed position peaked at $673K in Q1 2017.
362 funds tracked by Wall St. Rank held ResMed as of Q3 2017.

Based on Cutler Group's 13F filing for Q3 2017, filed 17 Oct 2017.